Application 091383
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LORAZEPAM | LORAZEPAM | CONCENTRATE;ORAL | 2MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65162-687 | Lorazepam | Lorazepam | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-687 | Lorazepam | Lorazepam | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-687 | Lorazepam | Lorazepam | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-687 | Lorazepam | Lorazepam | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-687 | Lorazepam | Lorazepam | Amneal Pharmaceuticals LLC | ANDA | Current |
| 70166-260 | Lorazepam | Lorazepam | Lohxa | ANDA | Current |